DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Erlinge D, Gurbel PA, James S. et al.
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: The GENERATIONS trial, a pharmacodynamics and pharma-cokinetic study in stable coronary disease patients.
J Am Coll Cardiol 2013;
62: 577-583.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.